实用心电学杂志2016，Vol.25Issue(5)：309-312,4.DOI:10.13308/j.issn.2095-9354.2016.05.002
遗传性长 QT 综合征的药物及器械治疗
Drug and device therapies of congenital long-QT syndrome
刘红彬1
作者信息
- 1. 050011 河北 石家庄，石家庄市第三医院心内科
- 折叠
摘要
Abstract
Congenital long-QT syndrome(LQTS)is characterized by the prolongation of QT in-terval in ECG and relevant torsade de pointes(TdP),which easily leads to sudden cardiac death. Its risk factors include the length of QTc interval,genotype,medical history of syncope,etc.The treatment of congenital LQTS involves β blockers,surgical left cardiac sympathetic denervation (LCSD),cardiac pacing and implantable cardioverter defibrillators(ICD).βblockers are the first-line treatment for all the LQTS patients.Cardiac pacing therapy is fit for LQTS patients complicating bradycardia,which can significantly reduce the recurrence rate of cardiac events,but not the mor-tality.High-risk LQTS patients should be implanted with ICD.Less subcutaneous complications of ICD are found and thus the therapy is worthy of being promoted.LCSD is poorly practical and is more suitable for those ICD-implanted patients frequently undergoing electroshock.关键词
遗传性/长QT综合征/β受体阻滞剂/心脏起搏/植入式心律转复除颤器Key words
heredity/long QT syndrome/βblockers/cardiac pacing/implantable cardioverter defibrillator分类
医药卫生引用本文复制引用
刘红彬..遗传性长 QT 综合征的药物及器械治疗[J].实用心电学杂志,2016,25(5):309-312,4.
